Disruption of embryonic vascular development in predictive toxicology
- 1 December 2011
- journal article
- review article
- Published by Wiley in Birth Defects Research Part C: Embryo Today: Reviews
- Vol. 93 (4) , 312-323
Abstract
Toxicity testing in the 21st century is moving toward using high‐throughput screening assays to rapidly test thousands of chemicals against hundreds of molecular targets and biological pathways, and to provide mechanistic information on chemical effects in human cells and small model organisms. First‐generation predictive models for prenatal developmental toxicity have revealed a complex web of biological processes with many connections to vasculogenesis and angiogenesis. This review examines disruption of embryonic vascular development as a potential adverse outcome pathway leading to developmental toxicity. We briefly review embryonic vascular development and important signals for vascular development (local growth factors and cytokines such as vascular endothelial growth factor‐A and TGF‐beta, components in the plasminogen activator system, and chemotactic chemokines). Genetic studies have shown that perturbing these signals can lead to varying degrees of adverse consequences, ranging from congenital angiodysplasia to fetal malformations and embryolethality. The molecular targets and cellular behaviors required for vascular development, stabilization and remodeling are amenable to in vitro evaluation. Evidence for chemical disruption of these processes is available for thalidomide, estrogens, endothelins, dioxin, retinoids, cigarette smoke, and metals among other compounds. Although not all compounds with developmental toxicity show an in vitro vascular bioactivity signature, many ‘putative vascular disruptor compounds’ invoke adverse developmental consequences. As such, an adverse outcome pathway perspective of embryonic vascular development can help identify useful information for assessing adverse outcomes relevant to risk assessment and efficient use of resources for validation. Birth Defects Research (Part C) 93:312–323, 2011.Keywords
This publication has 72 references indexed in Scilit:
- Developmental and Pathological AngiogenesisAnnual Review of Cell and Developmental Biology, 2011
- Microvascular Mural Cell Functionality of Human Embryonic Stem Cell-Derived Mesenchymal CellsTissue Engineering Part A, 2011
- Effects of Neonatal Exposure to Bisphenol A on Steroid Regulation of Vascular Endothelial Growth Factor Expression and Endothelial Cell Proliferation in the Adult Rat Uterus1Biology of Reproduction, 2010
- Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessmentEnvironmental Toxicology and Chemistry, 2009
- Visualization and experimental analysis of blood vessel formation using transgenic zebrafishBirth Defects Research Part C: Embryo Today: Reviews, 2007
- Genetic causes of vascular malformationsHuman Molecular Genetics, 2007
- Refinement of a morphological scoring system for postimplantation rabbit conceptusesBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2007
- Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitroReproductive Toxicology, 2007
- Assembly of Trunk and Limb Blood Vessels Involves Extensive Migration and Vasculogenesis of Somite-Derived AngioblastsDevelopmental Biology, 2001
- Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2Developmental Dynamics, 2000